Frontlight ResearchEarly access
Trial site
Samodzielny Publiczny Szpital Kliniczny nr 1 w Lublinie
- 6running trials
- 7closed trials
The trials here
What the 13 trials at this site are about, from their registry records.
- Conditions
- Atopic dermatitis (eczema)2 trials
- Glaucoma2 trials
- Haemophilia2 trials
- Myeloproliferative neoplasms2 trials
- Acute myeloid leukaemia1 trial
- Diabetic eye disease1 trial
- Diffuse large B-cell lymphoma1 trial
- High blood pressure1 trial
- Multiple myeloma1 trial
- Myelodysplastic syndromes1 trial
- Phase
- Phase 311 trials
- Phase 1/21 trial
- Phase 21 trial
- Status
- Completed6 trials
- Active, not recruiting5 trials
- Recruiting1 trial
- Terminated1 trial
- Lead sponsor
- Novo Nordisk A/S2 trials
- AbbVie1 trial
- Almirall, S.A.1 trial
- Celgene Corp.1 trial
- Eli Lilly and Company1 trial
- and 7 more
Running trials
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Acute myeloid leukaemia1 recruiting
Closed trials
Terminated
RVU120 in Patients With Intermediate or High-risk, Primary or Secondary Myelofibrosis
Active, not recruiting
Completed
Active, not recruiting
Completed
Completed
Long-term Safety and Efficacy Extension Trial of Bimatoprost SR
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026